1. Home
  2. CPRX vs APPN Comparison

CPRX vs APPN Comparison

Compare CPRX & APPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CPRX
  • APPN
  • Stock Information
  • Founded
  • CPRX 2002
  • APPN 1999
  • Country
  • CPRX United States
  • APPN United States
  • Employees
  • CPRX N/A
  • APPN N/A
  • Industry
  • CPRX Biotechnology: Pharmaceutical Preparations
  • APPN Computer Software: Prepackaged Software
  • Sector
  • CPRX Health Care
  • APPN Technology
  • Exchange
  • CPRX Nasdaq
  • APPN Nasdaq
  • Market Cap
  • CPRX 2.6B
  • APPN 2.3B
  • IPO Year
  • CPRX 2006
  • APPN 2017
  • Fundamental
  • Price
  • CPRX $24.69
  • APPN $29.34
  • Analyst Decision
  • CPRX Strong Buy
  • APPN Hold
  • Analyst Count
  • CPRX 8
  • APPN 6
  • Target Price
  • CPRX $32.50
  • APPN $37.00
  • AVG Volume (30 Days)
  • CPRX 1.5M
  • APPN 592.6K
  • Earning Date
  • CPRX 05-07-2025
  • APPN 05-01-2025
  • Dividend Yield
  • CPRX N/A
  • APPN N/A
  • EPS Growth
  • CPRX 107.94
  • APPN N/A
  • EPS
  • CPRX 1.31
  • APPN N/A
  • Revenue
  • CPRX $491,734,000.00
  • APPN $617,022,000.00
  • Revenue This Year
  • CPRX $15.17
  • APPN $12.67
  • Revenue Next Year
  • CPRX $8.28
  • APPN $10.86
  • P/E Ratio
  • CPRX $18.96
  • APPN N/A
  • Revenue Growth
  • CPRX 23.49
  • APPN 13.14
  • 52 Week Low
  • CPRX $14.47
  • APPN $26.28
  • 52 Week High
  • CPRX $26.16
  • APPN $43.33
  • Technical
  • Relative Strength Index (RSI)
  • CPRX 62.78
  • APPN 40.28
  • Support Level
  • CPRX $20.68
  • APPN $28.81
  • Resistance Level
  • CPRX $26.16
  • APPN $32.47
  • Average True Range (ATR)
  • CPRX 0.83
  • APPN 1.13
  • MACD
  • CPRX 0.36
  • APPN 0.11
  • Stochastic Oscillator
  • CPRX 75.21
  • APPN 15.63

About CPRX Catalyst Pharmaceuticals Inc.

Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers Firdapse, a proprietary form of amifampridine phosphate for the treatment of patients with Lambert-Eaton myasthenic syndrome.

About APPN Appian Corporation

Appian Corp is a low-code enterprise platform-as-a-service company focusing on business process management. The company's Appian platform is an integrated automation platform providing tools for organizations to design, automate, and optimize end-to-end processes and complex business operations. Capabilities include case management, robotic process automation, artificial intelligence, data fabric, and process mining. The company also provides maintenance and support as well as consulting services and training related to its platform. The majority of its revenue is subscription-based with the remainder from services, with much of its subscription revenue being derived from its cloud-based platform. Geographically, the company derives maximum revenue from its business in the United States.

Share on Social Networks: